Promethera Biosciences Funding: $132M Raised, Series D
Promethera Biosciences is based in Mont-Saint-Guibert, Belgium. It has raised $132M in total funding. Latest round: Series D.
Promethera Biosciences funding overview
Promethera Biosciences is based in Mont-Saint-Guibert, Belgium. Promethera Biosciences has raised $132M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2019. The round record for Promethera Biosciences runs through 2019; nothing later has been disclosed. Investors on record include Shinsei Capital Partners, Cyril Janssen, Marc Speeckaert, Olivier VAN DER Rest, Ci:z Investment, Korea Investment Partners and 5 others. 11 distinct backers are named across the disclosed rounds.
Promethera Biosciences at a glance
Total raised
$132M
Latest round
Series D
Latest round date
May 2019
Headquarters
Mont-Saint-Guibert, Belgium
Notable investors
Shinsei Capital Partners, Cyril Janssen, Marc Speeckaert, Olivier VAN DER Rest, Ci:z Investment, Korea Investment Partners, MEDIPAL HOLDINGS CORPORATION, Mirae Asset Capital
Frequently asked about Promethera Biosciences funding
How much has Promethera Biosciences raised?
Promethera Biosciences has raised $132M in total disclosed funding across the rounds on record.
Who has invested in Promethera Biosciences?
Shinsei Capital Partners, Cyril Janssen, Marc Speeckaert, Olivier VAN DER Rest, Ci:z Investment, Korea Investment Partners are named among the investors backing Promethera Biosciences.
What was the latest Promethera Biosciences funding round?
The most recent disclosed round is a Series D, announced in May 2019.
Where is Promethera Biosciences based?
Promethera Biosciences is based in Mont-Saint-Guibert, Belgium.
When did Promethera Biosciences last raise?
The last disclosed Promethera Biosciences round closed in May 2019 at Series D.
Totals shown for Promethera Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Mont-Saint-Guibert and the investors behind them below.
